Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Effect of 17-α hydroxyprogesterone caproate on the production of tumor necrosis factor-α and the expression of cyclooxygenase-2 in lipopolysaccharide-treated gravid human myometrial explants

Abstract

Objective:

To determine whether 17-α hydroxyprogesterone (17-OHPC) alters tumor necrosis factor-α (TNF-α) production and the expression of cyclooxygenase type 2 (COX-2) in myometrium exposed to lipopolysaccharide (LPS).

Study Design:

Lower segment myometrial biopsies were obtained from non-laboring patients at term. Tissues were cultured in serum-free media with 17-OHPC (1 μM) and LPS (1 μg/ml), either alone or in combination. At 24 h, the production of tumor necrosis factor-α (TNF-α) and the expression of COX-2 was determined using enzyme linked immunosorbent assay and real-time (RT-PCR). Statistical analysis was performed using non-parametric testing. A P-value of <0.05 was considered significant.

Result:

17-OHPC had no effect on TNF-α production and COX-2 expression when compared with untreated myometrial explants (P=0.61 and P=0.95). LPS induced production of TNF-α (P=0.03) and expression of COX-2 (P=0.02). Treatment with 17-OHPC did not block LPS-induced TNF-α production (P=0.37) or COX-2 expression (P=0.12).

Conclusion:

In this pilot study, 17-OHPC did not affect the production of TNF-α or COX-2 expression in human myometrium.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M . Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increase risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419–424.

    Article  CAS  Google Scholar 

  2. Slater DM, Dennes WJ, Campa JS, Poston L, Bennett PR . Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol Hum Reprod 1999; 5 (9): 880–884.

    Article  CAS  Google Scholar 

  3. Sooranna SR, Lee Y, Kim LU, Mohan AR, Bennett PR, Johnson MR . Mechanical stretch activates type 2 cyclooxygenase via activator protein-1 transcription factor in human myometrial cells. Mol Hum Reprod 2004; 10 (2): 109–113.

    Article  CAS  Google Scholar 

  4. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004; 292 (4): 462–469.

    Article  CAS  Google Scholar 

  5. Goldenberg RL, Hauth JC, Andrews WW . Intrauterine infection and preterm delivery. N Engl J Med 2000; 342 (20): 1500–1507.

    Article  CAS  Google Scholar 

  6. Houben M, Nikkels P, van Bleek G, Visser G, Rovers M, Kessel H et al. The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS ONE 2009; 4 (8): e6572.

    Article  Google Scholar 

  7. Peltier M, Tee S, Smulian J . Effect of progesterone on proinflammatory cytokine production by monocytes stimulated with pathogens associated with preterm birth. Am J Reprod Immunol 2008; 60 (4): 346–353.

    Article  CAS  Google Scholar 

  8. Watari M, Watari H, DiSanto M, Chacko S, Shi G, Strauss J . Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol 1999; 154 (6): 1755–1762.

    Article  CAS  Google Scholar 

  9. Inglis S, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak F et al. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 1994; 171 (1): 5–10.

    Article  CAS  Google Scholar 

  10. Sadowsky D, Adams K, Gravett M, Witkin S, Novy M . Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 2006; 195: 1578–1589.

    Article  CAS  Google Scholar 

  11. Pu J, Zeng WY . Relationship among TNF-alpha gene promoter -308 site polymorphism, the levels of maternal serum TNF-alpha, and the mRNA expression placental TNF-alpha in preterm labor. Sichuan Da Xue Xue Bao Yi Xue Ban 2009; 40 (1): 77–80.

    CAS  PubMed  Google Scholar 

  12. Erkinheimo TL, Saukkonen K, Narko K, Jalkanen J, Ylikorkala O, Ristimaki A . Expression of cyclooxygenase-2 and prostanoid receptors by human myometrium. J Clin Endocrinol Metab 2000; 85: 3468–3475.

    CAS  PubMed  Google Scholar 

  13. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348 (24): 2379–2385.

    Article  CAS  Google Scholar 

  14. Facchinetti F, Dante G, Venturini P, Paganelli S, Volpe A . 17α-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery. Am J Perinatol 2008; 25: 503–506.

    Article  Google Scholar 

  15. Tyson-Capper AJ, Europe-Finner GN . Novel targeting of cyclooxygenase-2 (COX-2) pre-mRNA using antisense morpholino oligonucleotides directed to the 3′ acceptor and 5′ donor splice sites of exon 4: suppression of COX-2 activity in human amnion-derived WISH and myometrial cells. Mol Pharm 2006; 69 (3): 796–804.

    CAS  Google Scholar 

  16. Sexton D, O’Reilly M, Friel A, Morrison J . Functional effects of 17alpha- hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro. Reprod Biol Endocrinol 2004; 2 (1): 80.

    Article  Google Scholar 

  17. Hardy DB, Janowski BA, Corey DR, Mendelson CR . Progesterone receptor plays a major antiinflammatory role in human myomterial cells by antagonism of nuclear factor-κB activation of cyclooxygenase 2 expression. Mol Endocrinol 2006; 20: 2724–2733.

    Article  CAS  Google Scholar 

  18. Hatthachote P, Gillespie JI . Complex interactions between sex steroids and cytokines in the human pregnant myometrium: evidence for an autocrine signaling system at term. Endocrinology 1999; 140 (6): 2533–2540.

    Article  CAS  Google Scholar 

  19. Li A, Lee RH, Felix JC, Minoo P, Goodwin TM . Alteration of secretory leukocyte protease inhibitor in human myometrium during labor. Am J Obstet Gynecol 2009; 200 (3): 311. e1–311. e10.

    Article  Google Scholar 

  20. Jain JK, Li A, Minoo P, Nucatola DL, Felix JC . The effect of nonoxynol-9 on human endometrium. Contraception 2005; 71: 137–142.

    Article  CAS  Google Scholar 

  21. Li A, Felix JC, Hao J, Minoo P, Jain JK . Menstrual-like breakdown and apoptosis in human endometrial explants. Hum Reprod 2005; 20: 1709–1719.

    Article  CAS  Google Scholar 

  22. Li A, Felix JC, Minoo P, Amezcua CA, Jain JK . Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells. Fertil Steril 2005; 84: 202–211.

    Article  CAS  Google Scholar 

  23. Jain JK, Li A, Nucatola DL, Minoo P, Felix JC . Nonoxynol-9 induces apoptosis of endometrial explants by both caspase-dependent and -independent apoptotic pathways. Biol Reprod 2005; 73: 382–388.

    Article  CAS  Google Scholar 

  24. Nap AW, Dunselman GA, de Goeij AF, Evers JL, Groothuis PG . Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model. Hum Reprod 2004; 19 (10): 2180–2187.

    Article  CAS  Google Scholar 

  25. Ruddock NK, Shi S-Q, Jain S, Moore G, Hankins G, Romero R et al. Progesterone, but not 17-alpha hydroxyprogesterone caproate, inhibits human myometrial contractions. Am J Obstet Gynecol 2008; 199: 391.e1–391.e7.

    Article  Google Scholar 

  26. Keiser S, Veillon E, Parrish M, Bennett W, Cockrell K, Fournier L et al. Effects of 17-hydroxyprogesterone on tumor necrosis factor-α-induced hypertension during pregnancy. Am J Hypertens 2009; 22 (10): 1120–1125.

    Article  CAS  Google Scholar 

  27. Veillon E, Keiser S, Parrish M, Bennett W, Cockrell K, Ray L et al. 17-hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats. Am J Obstet Gynecol 2009; 201 (3): 324. e1–323. e6.

    Article  Google Scholar 

  28. Amory J, Lawler R, Shields L . Hydroxyprogesterone caproate and progesterone increase tumor necrosis factor-alpha production in lipopolysaccharide stimulated whole blood from non-pregnant women. J Perinat Med 2005; 33 (6): 506–509.

    Article  CAS  Google Scholar 

  29. Johnson JWC, Lee PA, Zachary AS, Calhoun S, Migeon CJ . High-risk prematurity-progestin treatment and steroid studies. Obstet Gynecol 1979; 54 (4): 412–418.

    CAS  PubMed  Google Scholar 

  30. Hartikainen-Sorri A, Kauppila A, Tuimala R . Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol 1980; 56 (6): 692–695.

    CAS  PubMed  Google Scholar 

  31. Attardi BJ, Zeleznik A, Simhan H, Chiao JP, Mattison DR, Caritis SN . Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol 2007; 197 (6): 599.e1–599.e7.

    Article  Google Scholar 

  32. Benjamin D, Jost JP . Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. Nucleic Acids Res 2001; 29 (17): 3603–3610.

    Article  CAS  Google Scholar 

  33. Lockwood CJ, Kuczynski E . Risk stratification and pathological mechanisms in preterm delivery. Paediatr Perinat Epidemiol 2001; 15 (Suppl 2): 78–89.

    Article  Google Scholar 

  34. Jansen PW, Tiemeier H, Jaddoe VWV, Hofman A, Steegers EAP, Verhulst FC et al. Explaining educational inequalities in preterm birth: the generation r study. Arch Dis Child Fetal Neontal Ed 2009; 94 (1): F28–F34.

    Article  CAS  Google Scholar 

  35. Moutquin JM . Socio-economic and psychosocial factors in the management and prevention of preterm labour. BJOG 2003; 110 (Suppl 20): 56–60.

    Article  Google Scholar 

  36. Goffinet F . Primary predictors of preterm labour. BJOG 2005; 112 (Suppl 1): 38–47.

    Article  Google Scholar 

  37. ESHRE Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod 2000; 15: 1856–1864.

    Article  Google Scholar 

  38. ACOG Committee opinion no. 419. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008; 112: 963–965.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Drs Frank Stanczyk and Durlin Hickok and Adeza Biomedical Corporation for providing the 17-OHPC used in our experiment. We also acknowledge grant funding from Health Research Associates.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R H Lee.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, S., Li, A., Goodwin, T. et al. Effect of 17-α hydroxyprogesterone caproate on the production of tumor necrosis factor-α and the expression of cyclooxygenase-2 in lipopolysaccharide-treated gravid human myometrial explants. J Perinatol 30, 584–589 (2010). https://doi.org/10.1038/jp.2010.23

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2010.23

Keywords

Search

Quick links